Alzamend Neuro Inc ( ALZN) - Stock Earnings
ALZN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 9, 2026, midnight | — / — | — | — / — | — |
ALZN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -1.0 million USD | — USD |
| 2025Q4 | -2.2 million USD | — USD |
| 2026Q1 | -2.9 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ALZN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -9.9 million USD | — USD |
| 2025 | -4.5 million USD | — USD |
| 2026 | -8.8 million USD | — USD |
| 2026 Est. | — | — |
ALZN
Price: $1.52
52 week price:
Earnings Per Share: -2.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 216306
Market Capitalization: 5.5 million